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ABSTRACT
Genomic parasites have evolved distinctive lifestyles
to optimize replication in the context of the genomes
they inhabit. Here, we introduced new DNA into
eukaryotic cells using bacteriophage Mu DNA trans-
position complexes, termed ‘transpososomes’.
Following electroporation of transpososomes and
selection for marker gene expression, efficient
integration was verified in yeast, mouse and human
genomes. Although Mu has evolved in prokaryotes,
strong biases were seen in the target site distribu-
tions in eukaryotic genomes, and these biases
differed between yeast and mammals. In Saccharo-
myces cerevisiae transposons accumulated outside
of genes, consistent with selection against gene dis-
ruption. In mouse and human cells, transposons
accumulated within genes, which previous work
suggests is a favorable location for efficient expres-
sionofselectablemarkers.Naturallyoccurringtrans-
posons and viruses in yeast and mammals show
related, but more extreme, targeting biases, sug-
gesting that they are responding to the same pres-
sures. These data help clarify theconstraints exerted
by genome structure on genomic parasites, and
illustrate the wide utility of the Mu transpososome
technology for gene transfer in eukaryotic cells.
INTRODUCTION
The replication cycles of genomic parasites have evolved
to optimize replicative success in the context of the host
cells they inhabit (1,2). For example, the attachment sites
for integrating bacteriophages are commonly located in
regions of bacterial genomes that can tolerate insertion
without adverse eﬀects on the host cell (1,2). Here we
probe the relationship between genome organization and
the consequences of integration experimentally. We com-
pared DNA integration in the yeast, murine and human
genomes, which diﬀer radically in structure. The Sacchar-
omyces cerevisiae genome is composed of  69% coding
regions, and introns are rare (3). In contrast, in the mam-
malian genomes, transcription units comprise a minority
of the sequence. In humans,  30% of the genome is con-
tained within transcription units, and only 1.5% of the
genome is exons, the remainder of genes being intronic
(4,5). We used the bacterial transposon phage Mu to inte-
grate new sequences into the three genomes and found
that the recovered sites of Mu integration diﬀered radi-
cally between yeast and mammals, disclosing diﬀering
selective forces that can be understood in terms of diﬀer-
ing genome structure.
Bacteriophage Mu replicates its genome using DNA
transposition, and it is one of the most thoroughly studied
mobile genetic elements (6,7). The catalysis of the DNA-
breaking and -joining steps involved in Mu transposition
takes place within a nucleoprotein complex called the
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minimal in vitro system using MuA transposase pro-
tein and linear DNA molecules containing a 50-bp Mu
R-end segment in each end (8,10,11). The transpososome
directs transposon integration into any target DNA with
a low stringency of target sequence preference, and this
reaction constitutes the basis of Mu in vitro transpo-
sition technology (11). The technology has been used for
DNA sequencing (12), functional analyses of plasmid
DNA and virus genomes (11,13–17), protein engineering
for structure/function studies (18–21) and generation
of gene targeting constructions (22,23). In bacteria,
in vitro-assembled Mu transpososomes introduced by elec-
troporation are able to direct correct Mu integration, as
has been shown with several bacterial species (24,25). Here
we show for the ﬁrst time that Mu transpososome-
mediated gene delivery can be used in eukaryotic cells,
including yeast, mouse ES cells, human HeLa cells and
human ES cells.
For each species, custom Mu transpososomes were gen-
erated that directed integration of selectable marker genes
for each cell type. Thus, the cells surviving selection in
culture have been selected for both eﬃcient expression of
the marker gene and proper function of the cellular
genome after integration. Integration sites were recovered
from each cell type after selection, mapped by sequencing
and their locations were compared to previously mapped
genomic features. We found extreme diﬀerences among
cell types in the frequency of integration compared to
identiﬁable genomic landmarks. In yeast, integration
sites preferentially accumulated outside of genes compared
to the expectation for random integration, while in mam-
mals, integration sites accumulated in introns within
genes. These trends disclose the diﬀerent requirements for
genome function and gene expression in yeasts versus
mammals that govern the accumulation of newly inte-
grated DNA.
MATERIALS AND METHODS
Strainsand media
Eschericia coli DH5a (Life Technologies//Invitrogen,
Carlsbad, CA, USA) was used as a standard plasmid
host strain. It was grown in Luria Broth with supplemen-
tary antibiotics when required: ampicillin (100mg/ml),
kanamycin (10mg/ml).
Diploid S. cerevisiae strain FY1679 (MATa/MAT 
ura3-52/ura3-52 his3D200/HIS3 leu2D1/LEU2 trp1D63/
TRP1 GAL2/GAL2; (26) and its haploid derivative
FY-3a (MATa ura3-52; isolated in this study by random
spore analysis) were grown on YPD (1% yeast extract, 2%
peptone and 2% glucose) or minimal medium (0.67%
yeast nitrogen base and 2% glucose).
HeLa cells were grown in MEM supplemented with 10%
fetal calf serum, penicillin–streptomycin and L-glutamine
at 378C in the presence of 5% CO2. Mouse AB2.2-Prime
embryonic stem cells (Lexicon Genetics, Inc., The
Woodlands, TX, USA) were grown on gelatinized tissue
culture dishes in knockout DMEM supplemented with
15% deﬁned fetal calf serum, penicillin–streptomycin,
L-glutamine, non-essential amino acids, sodium pyruvate,
mercaptoethanol and 500U/ml LIF (leukemia inhibitory
factor) at 378C in the presence of 5% CO2. Human FES29
embryonic stem cells were grown on MEF feeders as
described (27). The number of live mammalian cells was
determined by trypan blue staining.
Enzymes, reagentsand DNA techniques
Commercial proteins and reagents are listed in Supple-
mentary Table 1. MuA transposase proteins were puri-
ﬁed in collaboration with Finnzymes (Espoo, Finland)
as described (28). Oligonucleotides are listed in Supple-
mentary Table 2. Plasmids and yeast DNA were isolated
using appropriate Qiagen kits, and mammalian DNA as
described (29). Standard DNA techniques were performed
as described (30). DNA sequence determination was done
at the sequencing facility of the Institute of Biotechnology.
Southern hybridization was carried out using [a-
32P]-
labeled probes. Autoradiography was done using BAS-
1500 or FLA-5000 image readers (Fuji, Stamford, CT,
USA).
Plasmids and transposons
The yeast electroporation control plasmid pHTH36 is a
G418-selectable version of pYC2/CT (Invitrogen,
Carlsbad, CA, USA), and it was made by kanMX4-Mu
in vitro transposition. In vitro transposition assay target
plasmid pAPH7 is a derivative of pUC19 (New England
Biolabs, Ipswich, MA, USA), containing a cloned 6.6-kb
HindIII fragment of phage  . Transposons (details in
Supplementary Figure 1) were constructed in the
context of their carrier plasmids, isolated by BglII diges-
tion and puriﬁed by anion exchange chromatography as
described (11).
Transpososomes
Transpososomes were assembled as described (24). The
assembly reaction (80ml) contained 55 nM transposon
DNA fragment, 245 nM MuA, 150mM Tris–HCl pH
6.0, 50% (v/v) glycerol, 0.025% (w/v) Triton X-100,
150mM NaCl and 0.1mM EDTA. The reaction was car-
ried out at 308C for 4–5h. Following assembly, several
reactions were pooled, and reaction products were concen-
trated ( 10-fold) and desalted using Centricon YM-100
centrifugal cartridges as described (25). Alternatively, the
concentration step was done using polyethylene glycol
(PEG 6000) precipitation as described (31). The pellet
was resuspended in storage buﬀer (10mM Tris–HCl
pH 6.0, 0.5% glycerol, 0.1mM DTT). The assembly and
concentration of transpososomes were monitored by aga-
rose/BSA/heparin gels as described (24). Preparations
were frozen in liquid nitrogen and stored at –808C. The
transpositional activity of these preparations could be
measured by an in vitro transposition assay using a select-
able target plasmid and introduction of the reaction pro-
ducts into competent E. coli cells (11). The preparations
scored roughly 1 10
6 CFU/mg transposon DNA when
measured using 3.44-mg target plasmid (pAPH7) and
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8 CFU/mg
pUC19 DNA.
Yeast electrocompetent cells and theirelectroporation
Yeast cells were grown in YPD medium to a stationary
phase, diluted 1:10000 in fresh medium and grown to an
OD600 of  2. Cells were collected by centrifugation, resus-
pended in 1/4 culture volume of LiAc/DTT/TE (0.1M
lithium acetate, 10mM dithiotreitol, 10mM Tris–HCl
pH 7.5 and 1mM EDTA), and incubated for 1h at room
temperature. After centrifugation for 10min (3500g), cells
were washed with an equal volume of ice-cold water,
re-collected by centrifugation and resuspended in 1/10 of
the original culture volume of ice-cold 1M sorbitol. After
re-collection by centrifugation, the pellet was suspended in
ice-cold 1M sorbitol to yield a  200-fold concentration of
the original culture density. One hundred microliters of
fresh cell suspension ( 1 10
8 cells) was used for electro-
poration. An aliquot (1–2ml) of transpososome prepara-
tion (containing 1mg transposon DNA) or plasmid DNA
(20ng) was added to the cell suspension. Following incu-
bation on ice (5min), the mixture was transferred into a
chilled Bio-Rad cuvette (0.2-cm electrode spacing), and
electroporation was carried out using Genepulser II (Bio-
Rad, Hercules, CA, USA) with the following settings: vol-
tage 1.5kV (diploid strain FY1679) or 2.0kV (haploid
strain FY-3a); capacitance 25mF; resistance 200V.
Following electroporation, 0.9ml of YPD medium was
added, and cells were incubated for 2h at 308C. Cells
were plated on YPD plates containing G418 (geneticin,
200mg/ml) for the selection of the transposon marker
gene. Underthese conditions,  5–25%of thecells survived
electroporation (data not shown). The optimized protocol
yielded electroporation eﬃciencies for diploid and haploid
cells that routinely reached the levels of  1 10
6 and
 3 10
6 CFU/mg of introduced plasmid (pYC2/CT)
DNA, respectively. The reason for the apparent eﬃciency
diﬀerence between the two strains is not known but may be
related to diﬀerences in cell size or rigidity. We found that
when measured with plasmid pHTH36, using G418 selec-
tion, the apparent eﬃciencies were four to six times smaller
(Table 3), most probably reﬂecting the physiological dis-
similarity of the selection schemes used.
Electroporation of mammalian cells
HeLa and AB2.2 cells were harvested with trypsin-EDTA,
pH 7.4 and washed three times with 1 PBS (137mM
NaCl, 2.7mM KCl, 4.3mM Na2HPO4 and 1.47mM
KH2PO4). Standard electroporation mixtures contained
 1 10
6 HeLa cells or  1 10
7 AB2.2 cells in 800mlo f
1 PBS and 2mg of transposon DNA complexed with
MuA transposase. The cells were exposed to a single vol-
tage pulse (250V; 500mF) at room temperature, allowed
to remain in the cuvette (0.4-cm electrode spacing) for
10min and then plated onto tissue culture dishes. Selective
conditions consisted of 400mg/ml G418 for HeLa cells and
150mg/ml G418 for AB2.2 cells. Selection was initiated
2 days after electroporation, and G418-resistant colonies
were isolated for clonal propagation after  10 days
of selection. For the enumeration of colonies, cells
were ﬁxed with cold methanol and stained with 0.2%
methylene blue.
Human ES cells were detached using 1 Tryple select
(Gibco/Invitrogen, Carlsbad, CA, USA) according to the
supplier’s recommendations and resuspended in hESC
medium (27). Cells were then washed three times with
1 PBS. Transpososomes (5.0mg) were mixed with
 3 10
6 cells (800ml, in 1 PBS) in a 0.4-cm electrode
spacing cuvette and a single voltage pulse (320V; 200mF)
was given immediately. Medium (800ml) was then added,
and after a 5-min incubation at room temperature, the cells
were plated on feeders. Selection with puromycin (0.5mg/
ml) was initiated 2 days after electroporation
and continued until visible colonies appeared ( 7 days).
Propagation and enumeration of colonies was done as
described above.
Determination of transposon location
Genomic fragments with a transposon attached to its chro-
mosomal DNA ﬂanks were either self-ligated (ori-
containing transposons) to produce plasmids or cloned
into pUC19 (other transposons). DNA sequences of both
transposon borders were determined from the plasmids
using transposon-speciﬁc oligonucleotide primers. Some
borders from yeast chromosomes were sequenced using a
linker ligation method (32). Transposon borders from
hES cells were determined using inverse PCR. Two micro-
grams of genomic DNA was digested with a combination
of restriction enzymes (NheI+SpeI+XbaI or DraI+
HpaI+SnaBI). Following ligation, the DNA was used
as a template in PCR ampliﬁcation with transposon-
speciﬁc primers, yielding PCR products that were
sequenced. Genomic locations were identiﬁed using the
BLAST search at SGD (Saccharomyces Genome Data-
base; http://genome-www.stanford.edu/Saccharomyces/),
SDSC Biology WorkBench (http://workbench.sdsc.edu/),
Ensembl Genome Browser (http://www.ensembl.org/
index.html) release v41 (October 2006) or NCBI (http://
www.ncbi.nlm.nih.gov/).
For statistical analysis of Mu integration in mouse
cells, it was useful to compare integration site distribu-
tions to random expectation. For this, matched random
controls were generated. A large set of random sites in the
mouse genome was drawn computationally. However,
recovery of Mu integration sites using restriction enzymes
introduces a recovery bias favoring sites near suitable
restriction enzyme cleavage sites in the mouse genome.
This bias is addressed by the use of matched random
controls. Each random site generated in silico was anno-
tated for proximity to restriction enzyme recognition
sites. For each experimental site of Mu integration, the
distance to the restriction site used for recovery was mea-
sured, then 10 random sites were drawn that were the
same distance from a recognition site for the same
enzyme. The statistical analysis (Supplementary Text 1)
preserved the pairing between Mu integration sites and
matched random controls. This matching procedure
‘washes out’ recovery biases due to placement of restric-
tion enzyme recognition sites, which otherwise can be
severe.
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Production of Mu transpososomesand verification of
correctintegration
Mu transpososomes were assembled by incubating mini-
Mu transposon DNA with MuA transposase (Supple-
mentary Figure 1), and correct assembly was veriﬁed by
agarose gel electrophoresis (Supplementary Figure 2).
Transpososome preparations were then concentrated
 10-fold for gene delivery. As negative controls in gene
delivery experiments, we used naked transposon DNA
without the addition of transposase, and transpososome
preparations made using an active site mutant transposase
MuA(E392Q) deﬁcient for catalysis (33).
Two features of the integrated transposons could be
checked to assess whether DNA integration was mediated
by MuA in yeast and mammalian cells. Authentic Mu
integration generates a 5-bp duplication at the targeted
locus. Integrants were analyzed from yeast, mouse and
human cells, and the correct length target sequence dupli-
cation was found in 158/168 yeast, 235/299 mouse inte-
grants and 14/14 human integrants analyzed (Tables 1
and 2 and Supplementary Tables 3 and 4). Another test
for correct Mu integration involved analyzing the
sequences duplicated at the site of insertion. A consensus
sequence for the duplicated region, 50-N-T/C-G/C-G/A-
N-3, has been observed both in vivo in bacteria and in
in vitro transposition reactions (34,35). We analyzed the
distribution of nucleotides in duplicated pentamers from
yeast and mouse ES cells (Supplementary Figures 3 and
4), and evaluated the data from human HeLa and ES cells
(Tables 1 and 2). All the results agreed well with those of
the previous studies, supporting the idea that the integra-
tions were mediated by MuA transposase.
Below we describe the use of Mu transpososomes to
integrate new genes in yeast, mouse and human cells,
then the distribution of integration sites relative to geno-
mic features in each cell type.
Table 1. Integration of transposon into human HeLa cell genome
Clone Sequence
a Chromo-
some
Band Location of
duplicated
pentamer
Gene(s) Transposon
orientation
c
RGC16 aggaggaagaACCAG(Kan/Neo-LoxP-Mu
b)
ACCAGgcacatgctg
8 q24.21 128363625-29 FAM84B–MYC Intergenic
RGC26 ttaaatgaacTTCAG(Kan/Neo-LoxP-Mu)
TTCAGgaaaataatg
12 p12.3 15381980-84 PTPRO_HUMAN Intron +
RGC35 ttgttcagttCTGGT(Kan/Neo-LoxP-Mu)
CTGGTgactcattgg
2 q31.2 179679743-47 NP_775919.2–SESTD1 Intergenic
RGC200.1 agggggatccCCGGC(Kan/Neo-p15A-Mu)
CCGGCccctgctgcc
5 q35.3 179178676-80 MGAT4B–SQSTM1 Intergenic
RGC204.1 ttgagtcaagAGGGG(Kan/Neo-p15A-Mu)
AGGGGgaagtccggg
1 c21.3 149586575-79 ENSESTG00000020135 Intron +
RGC205.1 aagcatcaggCTGGG(Kan/Neo-p15A-Mu)
CTGGTcaggtggagg
1 p36.13 16855907-11
16949721-25
ENSESTGG00000008139
ENSESTGG00000008135
Intron
Intron
 
 
RGC209.1 cccagacttcACCAT(Kan/Neo-p15A-Mu)
ACCATtgtgtcatac
1 q21.3 152313986-90 Nup210L Intron +
RGC210.1 caacaatttcATAGG(Kan/Neo-p15A-Mu)
ATAGGgttcagccta
20 q12 38737377-81 RP1-191L6.2-001–MAFB Intergenic
RGC214.1 ttgcagtgagCCGAG(Kan/Neo-p15A-Mu)
CCGAGatcctgccac
5 q13.3 75118286-90 NP_001013738.1–SV2 Intergenic
aTarget site duplications are shown in capitals.
bTransposon is the same as Kan/Neo-Mu, except that it contains two loxP sites ﬂanking the Kan/Neo gene.
cTranscription from the transposon compared with the direction of local transcription within the speciﬁed genomic location; +, same direction;
 , opposite direction.
Table 2. Integration of the transposon into the human embryonic stem cell genome
Clone Sequence
a Chromosome Band Location of
duplicated
pentamer
Gene(s) Transposon
orientation
b
1 ttgcccaggcTGGAG (Puro-eGFP-Mu)TGGAGtacagtggct 1 p34.3 36223437-41 EIF2C3 Intron  
4 agccaccgcgCCCGG(Puro-eGFP-Mu)CCCGGccaatcctgg 5 q31.1 133903082-86 PHF15 Intron +
5
c tcttcaaataGAGAT(Puro-eGFP-Mu)GAGATggagaatcac 18 p11.1 5408820-24 EPB41L3 Intron +
8 tgtaactcacCCCTG(Puro-eGFP-Mu)CCCTGgaaggaggct 17 q25.3 72973536-40 SEPT9 Intron +
9 ggctactgtgGGCAC(Puro-eGFP-Mu)GGCACacacagatac 3 q25.1 152372945-49 MED12L Intron +
aTarget site duplications are shown in capitals.
bTranscription from the transposon compared with the direction of local transcription within the speciﬁed genomic location; +, same direction;
 , opposite direction.
cPossibly contains two transposons (Figure 4), but inverse PCR used for sequencing only gives one integration site.
e148 Nucleic Acids Research, 2008, Vol. 36, No. 22 PAGE 4 OF13Mu integration in yeast cells
Transpososome preparations were electroporated sepa-
rately into diploid (FY1679) and haploid (FY-3a) yeast
recipient strains using optimized pulse parameters for
each of the strains (see ‘Materials and methods’ section),
then cells were selected for G418 resistance (Table 3).
When KanMX4-Mu was used, more than 1000 CFU/mg
introduced transposon DNA were obtained with the
haploid-recipient strain. The diploid strain yielded  200
CFU/mg of input KanMX4-Mu transposon DNA. When
the longer KanMX4-p15A-Mu transposon was used, the
number of G418-resistant colonies was roughly half of
that obtained with KanMX4-Mu. Control electropora-
tions yielded no or few resistant colonies in repeated
experiments (Table 3 and data not shown).
Southern hybridization was used to detect the presence
of transposon DNA and estimate the transposon copy
number in 179 G418-resistant isolates (49 haploid, 130
diploid). A representative autoradiograph portraying
17 (diploid) isolates is shown in Figure 1. Of these
17 clones, 15 generated one prominent band when the
genomic DNA was cut with enzymes that did not cleave
the transposon DNA (BamHI+BglII), and two bands
were generated if the transposon was cut once (HindIII).
Two isolates produced more complex patterns. These data
and additional sequencing data (below) indicated that the
15 clones each contain a single-copy genomic transposon
integration, while the more complex patterns arose due to
integration into the yeast two micron (2m) plasmid.
Altogether, 49 haploid integrant strains revealed 45 iso-
lates with a single chromosomal integration and for iso-
lates with a single plasmid integration. Of the 130 diploid
integrant strains studied, 107 showed a single transposon
integration in a chromosomal locus, and 22 isolates dis-
played a single transposon integrated in the 2m plasmid.
Notably, only one isolate contained two transposons, one
in the chromosome and the other in the plasmid.
Mu integration in murineES cells
Kan/Neo-p15A-Mu transpososomes were introduced
into murine ES cells by electroporation, and G418 resis-
tance was selected (Table 4), yielding 2400CFU/mg DNA.
Figure 1. Southern analysis of transposon insertions into S. cerevisiae genome. Genomic DNA of 17 G418-resistant yeast clones (diploid strain
FY1679) was digested with BamHI+BglII (left) or HindIII (right) and probed with labeled kanMX4 DNA. (Lanes 1–17) Insertion mutants, (lane C)
Genomic DNA of the original FY1679 recipient strain as a negative control, (lane P) Plasmid DNA containing the kanMX4-Mu transposon digested
with HindIII as a positive control, fragment sizes on the left.
Table 3. Number of colonies obtained on selection plates following electroporation into diploid and haploid yeast cells
a
DNA Transposase Selection Colonies generated (CFU/mg DNA)
FY1679
b FY-3a
c
KanMX-Mu MuA (wild-type) YPD+G418 197   20
d 1117   401
KanMX-Mu MuA(E392Q) YPD+G418 0 1
KanMX-Mu None YPD+G418 0 0
KanMX-p15A-Mu MuA (wild-type) YPD+G418 53   27 583   247
KanMX-p15A-Mu MuA(E392Q) YPD+G418 0 0
KanMX-p15A-Mu None YPD+G418 0 0
pHTH36
e None SC-ura 1.6   10
6 2.8   10
6
pHTH36 None YPD+G418 2.6   10
5 7.2   10
5
aThe optimal electroporation parameters used are diﬀerent for the two strains, not allowing a direct comparison between the strains.
bDiploid S. cerevisiae strain (26).
cHaploid derivative of FY1679 (this study).
dReactions with wild-type MuA transposase were electroporated in triplicate. Average number of colonies   SD is indicated.
eElectroporation of plasmid pHTH36 DNA served as a control for competence status.
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mg DNA. Transfection of naked transposon DNA yielded
 100CFU/mg DNA (Figure 2A). Thus, the active trans-
pososomes enhanced the transfection eﬃciency about
20-fold compared to the linear transposon or about
60-fold compared to the inactive transpososomes.
Approximately 0.2% of the cells that survived electro-
poration were stably transfected.
Southern hybridization was used to verify the presence
of transposon DNA and assess the copy number in several
G418-resistant isolates. We repeatedly recloned primary
isolates to produce cell lines that originated from a
single cell. Overall, 47 clonal cell lines were established.
An analysis of 16 clones is shown in Figure 2B. Genomic
DNA was digested with BamHI and BglII, which did not
cut the transposon. Fourteen of these clones produced one
band and two clones showed two bands, indicative of
integration by one and two transposons, respectively.
Altogether, 41 clones contained a single transposon inte-
gration, ﬁve clones two integrations and one clone three
integrations. Thus, a majority of the isolated G418-resis-
tant clones contained a single integrated transposon.
Mu integration in HeLacells
As a ﬁrst application in human cells, a Kan/Neo-loxP-Mu
transpososome preparation was used to electroporate
HeLa cells. Following selection for G418 resistance,
 640 and  25 CFU/mg transposon DNA for transposo-
somes and control naked transposon DNA were obtained.
The experiment was then repeated using a Kan/Neo-
p15A-Mu transpososome preparation, and the yield of
G418-resistant colonies was  400 CFU/mg transposon
DNA. These data indicated that although naked transpo-
son DNA can generate G418-resistant colonies with a
low-frequency, evidently reﬂecting integration by non-
homologous recombination, the use of transpososome
preparation boosts the transformation eﬃciency up to
25-fold in HeLa cells.
We used Southern hybridization to analyze transposon
DNA in HeLa cells. Figure 3 shows a Southern analysis of
19 HeLa cell clones resistant to G418. Seventeen isolates
showed a single band, indicating single-copy insertions.
Two isolates produced two bands of similar intensity,
evidently reﬂecting the integration of two transposons.
Thus, most of the analyzed HeLa clones contained only
one integrated transposon copy in the genome.
Mu integration into thehESC genome
To establish conditions for human ES cell modiﬁcation,
we electroporated Puro-eGFP-Mu transpososomes into
the hESC cell line FES29. Following puromycin selection,
the yield of resistant colonies was  2200 and  65 CFU/mg
for transpososomes and control naked DNA, respectively
(Figure 4A). Expression of eGFP from the transposon
construct was evaluated using FACS analysis (Supple-
mentary Figure 5). Southern hybridization was used to
verify the transposon integration in the genomic DNA
(Figure 4B). Eight isolates produced only one distinct
band hybridizing to the transposon-speciﬁc probe. One
of the clones gave rise to two bands indicative of possible
integration of two transposons. Thus, the Mu-mediated
gene delivery technology can be used to modify human
stem cells.
Figure 2. Analysis of transpososome-mediated gene delivery into mouse
ES cells. (A) Eﬃciency. Pre-assembled transpososomes made with Kan/
Neo-p15A-Mu transposon were introduced into mouse cells by electro-
poration. Following G418 selection, surviving cell colonies were stained
with methylene blue. Gene delivery was analyzed using transpososomes
made with wild-type MuA protein (left) and active site mutant
MuA(E392Q) (middle). Analysis was done also with linear transposon
DNA (right). (B) Southern analysis of transposon insertions into the
mES cell genome. Genomic DNA of 17 G418-resistant mES cell clones
was doubly digested with BamHI+BglII and probed with labeled
Kan/Neo-p15A-Mu transposon DNA. (Lanes 1–17) Transposon inser-
tion mutants. (Lane C) Genomic DNA of the original AB2.2 recipient
strain as a negative control. (Lane P) AB2.2 genomic DNA spiked with
transposon DNA as a positive control. (Lane M) Size marker. The
cross-hybridizing band present in all genomic DNA samples served as
a loading control.
Table 4. Electroporation of mouse embryonic stem cells (AB2.2) with
Kan/Neo-Mu transpososomes
Transposase G418-resistant
colonies generated
(CFU/mg DNA)
a
Survival of
cells after
electroporation
(%)
b
Survived cells
transformed
(%)
MuA (wild-type) 2376 324 83 0.20
MuA(E392Q) 38 12 79 0.01
None 98 26 77 0.01
aTranspososomes were electroporated in triplicate, average number of
colonies SD are indicated.
b4.6   10
6 viable cells were electroporated, plated in appropriate dilu-
tions and survival was determined in growth medium without selection.
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The sequences ﬂanking the transposon DNA were deter-
mined and mapped to the S. cerevisiae genome sequence.
Integration sites were distributed over all the yeast chro-
mosomes (Supplementary Figure 6). For diploid cells, 102
sites were available for the statistical analysis of target site
selection, and 37 sites for haploid cells (Supplementary
Table 3). For comparison, a random set of  10 000 inte-
gration sites was generated in silico and analyzed in par-
allel (Table 5).
The S. cerevisiae genome is composed of about  69%
open reading frames (ORFs), and introns are rare. For the
random data set, 69% of integration sites were in ORFs
(Figure 5A). For the experimental Mu integration site
data sets, genes comprised 46% of sites for diploid and
24% for haploid, signiﬁcantly diﬀerent from random
(P<0.001 for comparison of either to random). Thus,
after integration of Mu DNA into the yeast genome and
selection for expression from the marker gene, integration
sites accumulated outside the yeast genes. This even held
true for the diploid strain, where two copies of each gene
were present.
Yeast genes that are essential for growth have been
cataloged experimentally, allowing the relationship
between Mu integration and essential genes to be assessed.
The random data set showed 13% integration in essential
genes (Figure 5B). For Mu integration in diploids,
the ﬁgure was 11%, while for haploid the ﬁgure was
0%. For haploids, there was a signiﬁcant reduction in
integration sites in essential genes compared to random
expectation (P=0.036; Fisher’s exact test for comparison
over all sites), while for diploids there was no signiﬁcant
diﬀerence (P=0.66). Presumably, interruption of essen-
tial genes by Mu integration in the haploid strain caused
reduced growth, so that cells harboring these integrants
did not appear in the selected population, whereas in
diploids the other gene copy was suﬃcient to complement.
Seventeen integrations were found in rDNA. These
could not be mapped to a speciﬁc location due to the
repeated structure of the rDNA region. The proportion
of integration sites in rDNA in the two yeast strains
were 12% (diploid) and 14% (haploid), compared to
0.3% in the random set, showing a strong favoring of
integration in the rDNA cluster (P<0.001 for comparison
of either experimental set to random) (Figure 5C).
The S. cerevisiae strains studied contain the endo-
genous 2m plasmid, a 6-kb circular DNA present at
60–100 copies per cell. Nineteen Mu transposon integra-
tions were found in the 2m plasmid. Because copy number
is not known precisely, it is not possible to analyze inte-
gration frequency statistically. Nevertheless, it seems
probable that Mu integration events also accumulated to
a greater extent than expected by chance in the 2m
plasmid.
Integrationtarget site selection inmurine EScells
To analyze the distribution of Mu integration sites in the
mouse genome, we determined the sequence of 299 Mu
integration sites in murine ES cells (Supplementary
Table 4). Both left and right junctions between Mu
DNA and murine DNA were sequenced. A perfect 5-bp
duplication of the target site, was found in 235 of the
integration sites mapped (Supplementary Table 4A).
Some of the clones which lacked the target duplication
had deletions, the length of which typically ranged from
1bp to several kilobases, and a few clones contained some
extra DNA (Supplementary Table 4B). These could have
occurred by (i) integration by non-homologous recombi-
nation into the genome; (ii) integration of two Mu
sequences near one another, followed by recombination
between the two; or (iii) integration by transposition fol-
lowed by non-conventional processing of the transposition
intermediate, involving a double-strand break [for a plau-
sible model see (17)]. Also nested transposons formed by
Figure 3. Southern blot analysis of transposon insertions into HeLa cell genome. Chromosomal DNA was doubly digested with BamHI+BglII and
probed with labeled Kan/Neo-p15A-Mu transposon DNA. A total of 19 diﬀerent G418-resistant clones are analyzed, some with their siblings
(bracketed) for the veriﬁcation of clonality. (Lane C) Genomic DNA of the recipient HeLa cell line as a negative control. (Lane P) HeLa cell DNA
spiked with transposon DNA as a positive control. (Lane M) Size marker.
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were detected, in some cases accompanied by additional
rearrangements. We also sequenced some insertion sites
from control electroporations, and patterns indicative of
non-homologous recombination were revealed (Supple-
mentary Table 4C and D).
A collection of 214 Mu integration sites in mice was
available for statistical analyses (Table 5). This collection
was compared to a randomly generated group of control
integration sites (Supplementary Text 1). All chromosomes
except Y hosted at least four Mu integration events (Sup-
plementary Figure 7). Integration in the mouse genome has
also been extensively characterized for murine leukaemia
(MLV) and human immunodeﬁciency virus (HIV), so data
sets for these retroviruses (Table 5) were included for com-
parison in the analysis (Figure 6).
The Mu integration sites were found to be enriched in
transcription units compared to random—fully 43% of
Mu integration sites were in transcription units, while
only 31% of the control sites were in transcription units
(P=0.0001; Fisher’s exact test). Figure 6A shows a com-
parison to MLV and HIV, where each data set has been
normalized to random expectation. Mu integration resem-
bles MLV in modestly favoring integration in transcrip-
tion units. In HIV integration, this preference is more
pronounced. Both MLV and Mu strongly favored integra-
tion near CpG islands (Figure 6B), which are regions
enriched in the rare CpG dinucleotide that often corre-
spond to regulatory regions. Mu integration was also
strongly favored in gene dense regions (Figure 6C) and
regions of high transcriptional intensity (a measure that
combines transcription activity with gene density;
Figure 6D). Lastly, Mu integration was favored in G/C
rich regions (Figure 6E). In general Mu integration
resembled MLV integration in these genome features,
although the MLV trend was in each case somewhat
more pronounced.
Summaries of Mu integration frequency, relative to
54 forms of genomic annotation, can be found in Supple-
mentary Text 1. This analysis includes quantiﬁcation of
the variables in Figure 6, but analyzed over multiple
window sizes, and also integration frequency relative
to additional types of annotation, such as histone post-
translational modiﬁcation. The single strongest factor
positively correlating with Mu integration frequency is
the primary sequence of the 20bp at the site of integration
(abbreviated ‘score.20’). In addition, many of the features
analyzed showed signiﬁcant correlations with Mu integra-
tion frequency, raising the question of which eﬀects are
most meaningful. Many types of genomic annotation are
Figure 4. Analysis of transpososome-mediated gene delivery into
human ES cells. (A) Expression of eGFP. Human ES cell line FES29
was electroporated with Puro-eGFP-Mu transposons and selected for 2
days with puromycin. Surviving ﬂuorescent colonies were isolated and
further cultured as clonal cell lines for several passages. Most of the
colonies of the clonal isolates showed uniform GFP expression. Two
example clones are shown in the phase contrast (left) and ﬂuorescent
(right) micrographs. (B) Southern analysis of the insertions into the
hES cell genome. Genomic DNA of nine puromycin-resistant hES
cell clones was digested with BglII (left) or EcoRI (right) and probed
with labeled Puro-eGFP-Mu transposon DNA. (Lane P) Undigested
genomic DNA of clone 2 spiked with transposon DNA as a positive
control. (M) Size marker.
Table 5. Integration site data sets
Host organism Number of sites Transposon or virus Protein coding
genes (%)
Reference
Saccharomyces cerevisiae (haploid) 37 Mu transpososome 19.51 This study
Saccharomyces cerevisiae (diploid) 102 Mu transpososome 38.46 This study
Saccharomyces cerevisiae 9930 Random in silico 68.89 This study
Mouse ES cell 214 Mu transpososome 43.46 This study
Mouse 2140 Random in silico 30.51 This study
Human HeLa cell 9 Mu transpososome 55.56 This study
Human ES cell 5 Mu transpososome 100.00 This study
Human 2178 Random in silico 36.00 (58)
Mouse 2309 HIV 60.29 (59)
Mouse 4083 MLV 41.22 (59)
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which types of features are particularly strong drivers of
Mu integration site selection, and which are ‘hitchhikers’
on other more important determinants.
To explore this, a conditional logit regression model
was used to investigate interaction among the 54 variables
(types of genomic annotation) and Mu integration fre-
quency (Supplementary Text 1). To accommodate the
large number of variables, Bayes Model Averaging was
applied as described in (36). This revealed that a simpliﬁed
model composed of only the local sequence eﬀect
(score.20), local G/C content, and histone H3K36 tri-
methylation (37) captured much of the Mu targeting pre-
ference in murine ES cells. H3K36 trimethylation
accumulates within transcription units, and its positive
association captures the favorable eﬀects of integration
within genes. Using the model, it is possible to show
that the local sequence eﬀect (score.20) largely accounts
for the favored integration near CpG islands, which is
consistent with the observation that the favored local
target sequence contains the CpG dinucleotide within it.
In summary, the dominant eﬀects disclosed using Bayes
Model Averaging included local sequence (score.20), the
local G/C content, and H3K36 trimethylation.
Integrationtarget site selection inhuman cells
The number of Mu integration sites analyzed in human
cells was low (Tables 1, 2 and 5), but nevertheless a sig-
niﬁcant eﬀect could be detected for integration frequency
in genes. For the Hela cell data, 5/9 integration sites
were in transcription units, and for ES cells 5/5 were in
transcription units. Pooling the integration sites for all
human cells, comparison to random shows a signiﬁcant
enrichment of Mu integration in transcription units
(P=0.0077).
DISCUSSION
In this paper we report the use of Mu transposomes to
integrate new DNA in S. cerevisiae, murine ES cells and
human HeLa and ES cells. Donor Mu DNAs were engi-
neered to contain marker genes selectable in each cell type,
allowing selection of cells containing at least one copy of
integrated Mu transposon. This allowed us to ask where
newly integrated Mu DNA accumulated in each of the
genomes tested. We found that the combined selection
for cell growth together with marker gene expression led
to opposite results in the yeast versus mammals—in yeast
the newly integrated DNA accumulated in regions
between genes, while in mammals Mu DNA accumulated
within genes. As is discussed below, this parallels the inte-
gration targeting preferences shown by genomic parasites
that have evolved to inhabit each cell type.
Mu technology forgene delivery
The Mu transpososome technology described here pro-
vides a simple and ﬂexible means of integrating new
DNA into many types of cells. Transpososomes can be
assembled in vitro, bypassing the need of expressing poten-
tially toxic transposases within cells. Host factors are not
required, and transpososomes can be conveniently con-
centrated and stored. In previous studies, we have used
Mu transpososomes for the mutagenesis of Gram-negative
and Gram-positive bacteria (24,25). Here we show that
yeast, murine cells, and human cells could all be eﬃciently
transduced by electroporation. The majority of integra-
tion events had the structures expected for MuA-mediated
integration. This included the characteristic 5-bp target
sequence duplication, and the favored sequence found at
the site of integration. In mouse ES cells, 10–20% of the
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Figure 5. Analysis of integration site distributions in yeast cells.
Comparison of integration target site distributions in haploid and
diploid strains, and comparison of each to random. (A) Percentage of
integration events in yeast open reading frames. (B) Percentage of inte-
gration events in experimentally deﬁned essential genes. (C) Percentage
of integration events in rRNA genes.
PAGE 9 OF 13 Nucleic Acids Research, 2008, Vol. 36,No. 22 e148Figure 6. Analysis of integration site distributions in murine cells. The experimentally determined Mu integration sites reported here were compared
to previously reported integration sites for MLV and HIV in the murine genome. In each ﬁgure, the proportion of Mu integration sites in each
category is divided by the proportion in matched random controls—a bar below the line at 1.0 indicates disfavored Mu integration compared to
random, while a bar above the line indicates favored integration. (A) Mu integration frequency in transcription units (deﬁned as RefGenes).
Comparison of Mu to random achieves P=5.9e-4. (B) Mu integration frequency within 5kb of the center of a CpG island. Comparison of Mu
to random achieves P=4.22e-7. (C) Analysis of Mu integration frequency in gene-dense regions. The murine genome was partitioned into 10 bins of
increasing gene density (analyzed over four megabase regions), then the proportion of integration quantiﬁed in each bin and divided by random.
Comparison of Mu to random achieved P=3.58e-10. (D) Analysis of Mu integration as a function of transcriptional intensity. Aﬀymetrix micro-
array data for murine ES cells was used to quantify transcriptional intensity. Transcriptional intensity was measured exactly as for gene density
described above, but only genes in more highly expressed upper half of all genes queried on the microarray were scored. Comparison of Mu to
random achieved P=6.43e-8. (E) Mu integration frequency as a function of G/C content. The G/C content was measured over 5-kb intervals.
Comparison of Mu to random achieves P=5.13e-14.
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indicated by abnormal DNA structures in the transposon
or genomic DNA. Taken together, this establishes Mu as
a convenient tool for the generation of stable cell lines and
insertional mutagenesis. Mu may also be useful for trans-
genesis and therapeutic gene transfer. It is notable that the
majority of Mu integrant clones contained only one trans-
poson copy per genome, constituting a desirable feature
for most applications.
Comparison to other transposon systems in eukaryotes
Mu transpososome technology is a useful addition to
transposon-based methods for gene transfer, because the
Mu target site preference and integration pattern is diﬀer-
ent from the others characterized. Sleeping beauty (SB)
elements favor A/T rich DNA (38) and particular target
site sequences (39,40). SB integration favors genes and
their upstream regulatory regions in some cell types
(36,38,39). SB elements also frequently target microsatel-
lite DNA during genomic integration (38). Piggyback
(PB) demonstrated non-random integration site selectiv-
ity, including high preference for regions surrounding
transcriptional start sites and within long terminal repeat
elements (41–43). Tol2 does not show preference for any
speciﬁc primary sequence but targets a characteristic local
deformation of DNA (44–46). Thus, for insertional muta-
genesis applications, it may be attractive to use Mu
together with other transposon systems to widen the
accessible target sites.
Positions of integrated Mu DNA in yeast
and mammalian cells
The most unexpected ﬁnding of this study was the oppo-
site biases in the targeting of Mu integration in yeast
and mammalian cells. Integration in yeast was disfavored
in genes, whereas in mammalian cells integration was
actually favored in genes. For mouse ES cells, our deepest
data for Mu in a mammalian cell type, a strong positive
eﬀect was also seen for H3K36 trimethylation, which
marks transcribed regions. Possibly H3K36 trimethylation
itself is involved directly in targeting, since integration
near sites of H3K36 trimethylation was more strongly
favored than integration in the transcription units
themselves.
The observed departures from random could be either
due to the initial targeting of Mu integration in each
genome, or due to diﬀerential outgrowth of cells harbor-
ing integration events at diﬀerent positions. We see evi-
dence for both types of eﬀects. Targeting directed by MuA
could be seen in the conserved pentamer at the host cell
site of integration (score.20). In murine cells, the multi-
variate modeling revealed that this largely accounts for
favored integration near CpG islands. Selection after
Mu integration likely took place in the haploid yeast,
where no integration events were detected in essential
genes, which is readily explained by selection after integra-
tion against disruption of essential functions.
In yeast, not only haploid but also diploid cells showed
reduced integration in genes. In S. cerevisiae 69% of the
genome is open reading frames, and introns are rare. Two
models may account for the depletion of integration in
genes in the diploids—(i) there may be eﬀects of gene
dosage at many genes, so that disruption of one copy is
selected against during growth; or (ii) genes truncated by
Mu integration may sometimes have enough dominant
negative activity to confer a growth disadvantage.
In mammalian cells, several studies of retroviral inte-
gration have suggested that proviruses located within
gene rich regions are well positioned for gene expression
(47,48). For mammals, transcription units comprise
roughly one-third of the genome, but exons are only
about 1.5%, so that most integration events within tran-
scription units are in introns. Mu DNA in introns is well
positioned for marker gene expression, but gene disrup-
tion is minimized by splicing out of the Mu sequences.
Thus we hypothesize that the bias in favor of integration
in transcription units and gene-rich regions in mammalian
cells is a consequence of selection after integration for
eﬃcient marker gene expression.
From the multivariate analysis, G/C richness scored as
an important positive correlate of Mu integration fre-
quency. The favored local sequence for Mu integration
is G/C rich, potentially explaining the bias. In addition,
G/C richness is positively correlated with gene density,
which as described above may be favorable for marker
gene expression.
Genomestructure and integration of new sequences
Given the biases detected for Mu above, one might expect
that genomic parasites which inhabit the yeast or mam-
malian genomes might have evolved to respond to the
pressures detected in the Mu study. Indeed, examples
can be found for both genomic parasites of yeast and
mammals that naturally show the bias in de novo integra-
tion that were found here for Mu. HIV integration in
mammalian cells is strongly favored in transcription
units (49–52). A typical HIV infected cell only persists
for a day or two after infection before it is destroyed by
the cellular immune system or the toxicity of infection.
Thus there is strong pressure on HIV for eﬃcient gene
expression over a short time, and integration in gene-
rich regions promotes eﬃcient HIV gene expression (48),
likely explaining in the observed integration targeting pre-
ference. For the endogeous Ty and Tf transposons of
yeasts an opposite bias is seen. These elements are retro-
transposons, which replicate using retrovirus-like reverse
transcriptase and integrase enzymes, but all the steps take
place in a single cell. Thus, these elements are retrotran-
sposons and not retroviruses. Ty and Tf elements have
evolved to integrate in intergenic regions, and extensive
experimentation has revealed some of the molecular
tethering interactions involved (53–57). In the yeast
genome, which is densely packed with genes, and also
goes through haploid phases, selective pressures resulted
in accumulation of Mu integrants outside of genes. For
endogenous Ty and Tf elements, such tendencies have
evolved to optimize cohabitation in the yeast genome.
For mammalian genomes, which are exon sparse, Mu inte-
gration followed by selection for expression results in
accumulation within genes. For HIV, de novo integration
PAGE 11 OF13 Nucleic Acids Research, 2008, Vol. 36,No. 22 e148targeting has evolved to strongly favor genes, probably to
allow eﬃcient expression of the viral genome. Thus, the
studies with Mu help clarify the connections between
eukaryotic genome structure and selection pressures on
newly integrated DNA, thereby allowing us to better
understand the integration targeting preferences of natu-
rally occurring integrating parasites.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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